Licefreee Afterlice
NDC 51879-260
Product Information
Licefreee Afterlice is a OTC MONOGRAPH DRUG-approved product labeled by Tec Laboratories Inc.. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a product. This product entry covers the primary NDC 51879-260 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 51879-260?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- PRAMOXINE HYDROCHLORIDE (UNII: 88AYB867L5)
- PRAMOXINE (UNII: 068X84E056) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- TEA TREE OIL (UNII: VIF565UC2G)
- BENZETHONIUM CHLORIDE (UNII: PH41D05744)
- MENTHOL (UNII: L7T10EIP3A)
- POLYOXYL 35 CASTOR OIL (UNII: 6D4M1DAL6O)
- ALCOHOL (UNII: 3K9958V90M)
- WATER (UNII: 059QF0KO0R)
- PANTHENOL (UNII: WV9CM0O67Z)
- POLYQUATERNIUM-10 (400 CPS AT 2%) (UNII: HB1401PQFS)
* Please review the full disclaimer at the bottom of this page.
Patient Education
Pramoxine
Pramoxine is used to temporarily relieve pain and itching from insect bites; poison ivy, poison oak, or poison sumac; minor cuts, scrapes, or burns; minor skin irritation or rashes; or dry, itchy skin. Pramoxine also may be used to treat soreness, burning, itching, and pain from hemorrhoids (''piles'') and other minor rectal irritations or itching. Pramoxine is in a class of medications called topical anesthetics. It works by stopping nerves from sending pain signals.
[Learn More]
* Please review the full disclaimer at the bottom of this page.